Greater Cannabis Company (GCAN) Notes Payables (2016 - 2025)
Greater Cannabis Company's (GCAN) quarterly Notes Payables came in at $13775.0 in Q3 2025, down 91.96% year-on-year from $171437.0 in Q3 2024, and down 2.7% quarter-over-quarter from $14157.0 in Q2 2025.
Greater Cannabis Company (GCAN) Notes Payables (2016 - 2025) Analysis & Trends
Greater Cannabis Company's Notes Payables history runs 10 years deep, the most recent figure standing at $13775.0 for Q3 2025.
- On a quarterly basis, Notes Payables fell 91.96% year-over-year to $13775.0 in Q3 2025; TTM through Sep 2025 was $13775.0, a 91.96% decrease from a year earlier, with the FY2024 full-year figure at $171437.0, changed 0.0% from the prior year.
- Notes Payables eased to $13775.0 in Q3 2025 per GCAN's latest filing, from $14157.0 in the prior quarter.
- Across five years, Notes Payables topped out at $467437.0 in Q1 2022 and bottomed at $12453.0 in Q1 2021.
- The 5-year median for Notes Payables is $194294.0 (2021), against an average of $211901.6.
- Across the five-year window, Notes Payables sank 99.27% in 2021 and soared 3653.61% in 2022, its largest moves.
- Year by year, Notes Payables stood at $369095.0 in 2021, then plunged by 34.04% to $243437.0 in 2022, then fell by 29.58% to $171437.0 in 2023, then changed by 0.0% to $171437.0 in 2024, then tumbled by 91.96% to $13775.0 in 2025.
- Per Business Quant, the three latest GCAN Notes Payables figures stand at $13775.0 (Q3 2025), $14157.0 (Q2 2025), and $111357.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 13,775.00 |
| Jun 30, 2025 | 14,157.00 |
| Mar 31, 2025 | 111,357.00 |
| Dec 31, 2024 | 171,437.00 |
| Sep 30, 2024 | 171,437.00 |
| Jun 30, 2024 | 171,437.00 |
| Mar 31, 2024 | 171,437.00 |
| Dec 31, 2023 | 171,437.00 |
| Sep 30, 2023 | 207,437.00 |
| Jun 30, 2023 | 243,437.00 |
| Mar 31, 2023 | 243,437.00 |
| Dec 31, 2022 | 243,437.00 |
| Sep 30, 2022 | 307,437.00 |
| Jun 30, 2022 | 442,437.00 |
| Mar 31, 2022 | 467,437.00 |
| Dec 31, 2021 | 369,095.00 |
| Sep 30, 2021 | 298,756.00 |
| Jun 30, 2021 | 194,294.00 |
| Mar 31, 2021 | 12,453.00 |
| Dec 31, 2020 | 17,441.00 |